These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
140 related items for PubMed ID: 10052059
1. Effects of renal impairment on the disposition of orally administered enalapril, benazepril, and their active metabolites. Lefebvre HP, Laroute V, Concordet D, Toutain PL. J Vet Intern Med; 1999; 13(1):21-7. PubMed ID: 10052059 [Abstract] [Full Text] [Related]
3. Plasma concentrations of an angiotensin-converting enzyme inhibitor, benazepril, and its active metabolite, benazeprilat, after repeated administrations of benazepril in dogs with experimental kidney impairment. Kitagawa H, Eguchi T, Kitoh K, Ohba Y, Kondo M, Nakano M, Sasaki Y. J Vet Med Sci; 2000 Feb; 62(2):179-85. PubMed ID: 10720188 [Abstract] [Full Text] [Related]
4. Pharmacokinetics of the active metabolite of benazepril, benazeprilat, and inhibition of plasma angiotensin-converting enzyme activity after single and repeated administrations to dogs. King JN, Mauron C, Kaiser G. Am J Vet Res; 1995 Dec; 56(12):1620-8. PubMed ID: 8599524 [Abstract] [Full Text] [Related]
5. Pharmacokinetics of the angiotensin-converting-enzyme inhibitor, benazepril, and its active metabolite, benazeprilat, in dog. King JN, Maurer M, Morrison CA, Mauron C, Kaiser G. Xenobiotica; 1997 Aug; 27(8):819-29. PubMed ID: 9293618 [Abstract] [Full Text] [Related]
6. Effect of renal insufficiency on the pharmacokinetics and pharmacodynamics of benazepril in cats. King JN, Strehlau G, Wernsing J, Brown SA. J Vet Pharmacol Ther; 2002 Oct; 25(5):371-8. PubMed ID: 12423228 [Abstract] [Full Text] [Related]
7. The effects of age on the pharmacokinetics and pharmacodynamics of single oral doses of benazepril and enalapril. Macdonald NJ, Sioufi A, Howie CA, Wade JR, Elliott HL. Br J Clin Pharmacol; 1993 Sep; 36(3):205-9. PubMed ID: 9114905 [Abstract] [Full Text] [Related]
14. The disposition of [14C]-labelled benazepril HCl in normal adult volunteers after single and repeated oral dose. Waldmeier F, Kaiser G, Ackermann R, Faigle JW, Wagner J, Barner A, Lasseter KC. Xenobiotica; 1991 Feb; 21(2):251-61. PubMed ID: 2058180 [Abstract] [Full Text] [Related]
16. Renal actions of the new angiotensin-converting enzyme inhibitor benazepril hydrochloride. Levens NR. Arch Int Pharmacodyn Ther; 1988 Feb; 296():131-43. PubMed ID: 2853611 [Abstract] [Full Text] [Related]
17. Effect of experimental renal impairment on disposition of marbofloxacin and its metabolites in the dog. Lefebvre HP, Schneider M, Dupouy V, Laroute V, Costes G, Delesalle L, Toutain PL. J Vet Pharmacol Ther; 1998 Dec; 21(6):453-61. PubMed ID: 9885968 [Abstract] [Full Text] [Related]
19. Effect of hydrochlorothiazide on the pharmacokinetics of enalapril in hypertensive patients with varying renal function. Hersh AD, Kelly JG, Laher MS, Carmody M, Doyle GD. J Cardiovasc Pharmacol; 1996 Jan; 27(1):7-11. PubMed ID: 8656661 [Abstract] [Full Text] [Related]